Finance

Beta
Ask
Lists
PTIX:OTCMKTS
Protagenic Therapeutics Inc
$0.50
-26.54%
(-0.18) 1D
Jun 12, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PTIX...
Open
$0.54
High
$0.54
Low
$0.40
Mkt. cap
904.20K
Avg. vol.
3.62K
Volume
58.50K
52-wk high
$6.20
52-wk low
$0.25
Beta
0.96
Shares outstanding
1.81M
No. of employees
3
Open
$0.54
High
$0.54
Low
$0.40
Mkt. cap
904.20K
Avg. vol.
3.62K
Volume
58.50K
52-wk high
$6.20
52-wk low
$0.25
Beta
0.96
Shares outstanding
1.81M
No. of employees
3
News stories
From sources across the web
About Protagenic Therapeutics Inc
CEO-
Employees3
Founded1994
Headquarters-
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Dec 2024
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
134.58K
394.11K
273.23K
153.79K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
266.82K
814.26K
840.64K
771.32K
Operating expense
401.40K
1.21M
1.11M
925.10K
Total operating expenses
401.40K
1.21M
1.11M
925.10K
Operating income
-401.40K
-1.21M
-1.11M
-925.10K
Other non operating income
-
-3.61M
237.69K
3.14M
EBT including unusual items
-850.29K
-5.06M
-869.50K
2.21M
EBT excluding unusual items
-850.29K
-5.06M
-869.50K
2.21M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-850.29K
-5.06M
-869.50K
2.21M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-448.89K
-238.73K
-
-
Net interest expenses
-448.89K
-238.73K
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-1.20M
-1.10M
-912.53K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more